Home / Cancer
Cancer
| 4 min read
Wake Forest researchers have reprogrammed macrophages to target metastatic tumors in the brain, offering a potential new approach where conventional therapies struggle.
| 4 min read
Emerging clinical trials suggest that the gut microbiome plays a decisive role in how patients respond to immunotherapy.
| 4 min read
Live-cell assays quantify the genetic and metabolic influence on drug selectivity, enabling the development of more precise cancer therapies.
| 5 min read
A new model combines high-resolution experimental data with deep learning to reveal how non-coding DNA sequences control gene activity across different cell types.
| 5 min read
By tracking 5hmC in blood, researchers can capture active cancer pathways, identify novel drug targets, and monitor treatment response more efficiently than traditional approaches.
This virtual two-day symposium will gather researchers to present the latest breakthroughs in cancer immunology.
| 3 min read
Multi-omics analysis reveals a nine-gene signature linked to treatment failure in aggressive tumor behavior.
| 4 min read
A new CAR T therapy targets the immune cells that protect tumors, reshaping the tumor microenvironment and enabling host immune clearance.
| 4 min read
Integrating patient-derived xenografts and organoids can help researchers identify responsive tumor subsets, anticipate resistance, and strengthen translational confidence before clinical testing.
| 4 min read
Alzheimer’s diagnosis tests, AI-designed DNA circuits, bacterial insights, and more led the news this week.
| 4 min read
LYMPHIR delivers targeted therapy for a rare and incurable form of skin lymphoma while opening doors for broader immuno-oncology applications.
| 2 min read
The approach pairs ultrasound-induced tumor cell death with real-time antigen capture to drive both local and systemic immune responses.
